Cargando…
核酸干扰药物在抗肿瘤领域的机遇和挑战
As the discovery of RNA interference (RNAi) and the gradual conquering of a series of technical issues, a few of RNAi therapeutics have been approved in the non-tumor field abroad. With the advantages of high specificity, long duration of efficacy, and high success rate of development, RNAi therapeu...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346155/ https://www.ncbi.nlm.nih.gov/pubmed/35899445 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.20 |